T 2471/16 of 23.05.2018
- European Case Law Identifier
- ECLI:EP:BA:2018:T247116.20180523
- Date of decision
- 23 May 2018
- Case number
- T 2471/16
- Online on
- 22 October 2018
- Petition for review of
- -
- Application number
- 11196067.0
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Pharmaceutical composition for dermal use comprising calcipotriol and betamethasone for treating psoriasis
- Applicant name
- Leo Pharma A/S
- Opponent name
- Teva Pharmaceutical Industries Ltd.
PENTAFARMA S.A.
Generics [UK] Limited (trading as Mylan)
Sandoz B.V. - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 114European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Inventive step - (no)
Late-filed evidence - submitted with the statement of grounds of appeal - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.